@article{ref1,
title="5‐Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection",
journal="Journal of sexual medicine",
year="2008",
author="Erdemir, Fikret and Harbin, Andrew and Hellstrom, Wayne JG",
volume="5",
number="12",
pages="2917-2924",
abstract="Introduction.  Benign prostatic hyperplasia (BPH) is a common problem affecting middle-aged and elderly men. First-line medical therapy includes α 1blockers and 5α-reductase inhibitors (5ARIs), such as finasteride and dutasteride. 5ARI use has been associated with adverse sexual outcomes, including erectile dysfunction (ED), ejaculatory dysfunction (EjD), and decreased libido.<p />",
language="",
issn="1743-6095",
doi="10.1111/j.1743-6109.2008.01001.x",
url="http://dx.doi.org/10.1111/j.1743-6109.2008.01001.x"
}